What can we help you find?

Leading the way in transplantation

Filter results for:

CareDx’s AlloSeq cfDNA Represents a Minimally Invasive, Accurate Method to Detect Graft Injury as a Leading Solution for Transplant Patient Management in Europe

CareDx has developed AlloSeq cfDNA, a targeted NGS assay that relies on 202 single-nucleotide polymorphisms (SNPs) located throughout the genome to measure the dd-cfDNA in transplant recipients. The assay was designed to be fully compatible with any clinical laboratory setup and combines a streamlined workflow with a fully automated analysis software to accurately quantify dd-cfDNA in transplant recipients.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.